Relevance of bone graft viability in a goat transverse process model

Journal of Orthopaedic Research

Volumn 27, Issue 8, 2009, Pages 1055-1059

  Kruyt, Moyo C ^a   Delawi, Diyar ^a   Habibovic, Pamela ^b   Oner, F Cumhur ^a   Van Blitterswijk, Clemens A ^b   Dhert, Wouter J A ^a,c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF TWENTE   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Animal study; Bone; Graft; Spine; Tissue engineering; Viability

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOGRAFT; BIOLOGICAL MODEL; BONE DEVELOPMENT; BONE GRAFT; CANCELLOUS BONE; CELL MIGRATION; CORTICAL BONE; FLUOROCHROME STAINING; GOAT; GRAFT SURVIVAL; GRAFT VIABILITY; HISTOLOGY; ILIAC BONE; LUMBAR VERTEBRA; MORPHOMETRICS; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SPINE FUSION; TISSUE ENGINEERING; VERTEBRA;

ANIMALS; BONE REGENERATION; BONE TRANSPLANTATION; FEMALE; GOATS; GRAFT SURVIVAL; MODELS, ANIMAL; SPINAL FUSION; TISSUE SURVIVAL;

EID: 67749116096     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20830     Document Type: Article

References (30)

1. Yaszemski MJ, Payne RG, Hayes WC, et al. 1996. Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone. Biomaterials 17:175-185.
2. Delawi D, Dhert WJ, Castelein RM, et al. 2007. The incidence of donor site pain after bone graft harvesting from the posterior iliac crest may be overestimated: a study on spine fracture patients. Spine 32:1865-1868.
3. Banwart JC, Asher MA, Hassanein RS. 1995. Iliac crest bone graft harvest donor site morbidity. A. statistical evaluation. Spine 20:1055-1060.
4. Price CT, Connolly JF, Carantzas AC, et al. 2003. Comparison of bone grafts for posterior spinal fusion in adolescent idiopathic scoliosis. Spine 28:793-798.
5. Langer R, Vacanti JP. 1993. Tissue engineering. Science 260:920-926.
6. Burchardt H. 1983. The biology of bone graft repair. Clin Orthop 174:28-42.
7. Enneking WF, Burchardt H, Puhl JJ, et al. 1975. Physical and biological aspects of repair in dog cortical-bone transplants. J Bone Joint Surg [Am] 57:237-252.
8. de Bruyn PH, Kabisch WT. 1955. Bone formation by fresh and frozen autogenous and homogenous transplants of bone, bone marrow and periosteum. Am J Anatomy 96:375-417.
9. Boynton E, Aubin J, Gross A, et al. 1996. Human osteoblasts survive and deposit new bone when human bone is implanted in SCID mouse. Bone 18:321-326.
10. Zhang X, Xie C, Lin AS, et al. 2005. Periosteal progenitor cell fate in segmental cortical bone graft transplantations: implications for functional tissue engineering. J Bone Miner Res 20:2124-2137.
11. Zhang X, Naik A, Xie C, et al. 2005. Periosteal stem cells are essential for bone revitalization and repair. J Musculoskelet Neuronal Interact 5:360-362.
12. Kruyt MC, Dhert WJ, Oner C, et al. 2004. Osteogenicity of autologous bone transplants in the goat. Transplantation 77:504-509.
13. Tiyapatanaputi P, Rubery PT, Carmouche J, et al. 2004. A novel murine segmental femoral graft model. J Orthop Res 22:1254-1260.
14. Wilson CE, Kruyt MC, de Bruijn JD, et al. 2006. A new in vivo screening model for posterior spinal bone formation: comparison of ten calcium phosphate ceramic material treatments. Biomaterials 27:302-314.
15. Kruyt MC, Wilson CE, de Bruijn JD, et al. 2006. The effect of cell-based bone tissue engineering in a goat transverse process model. Biomaterials 27:5099-5106.
16. Boden SD, Schimandle JH, Hutton WC, et al. 1995. 1995 Volvo Award in basic sciences. The use of an osteoinductive growth factor for lumbar spinal fusion. Part I: biology of spinal fusion. Spine 20:2626-2632.
17. Boden SD, Schimandle JH, Hutton WC. 1995. An experimental lumbar intertransverse process spinal fusion model. Radiographic, histologic, and biomechanical healing characteristics. Spine 20:412-420.
18. Kanayama M, Cunningham BW, Weis JC, et al. 1997. Maturation of the posterolateral spinal fusion and its effect on load-sharing of spinal instrumentation. An in vivo sheep model. J Bone Joint Surg [Am] 79:1710-1720.
19. Habibovic P, Kruyt MC, Juhl MV, et al. 2008. Comparative in vivo study of six hydroxyapatite-based bone graft substitutes. J Orthop Res 26:1363-1370.
20. Urist MR. 1965. Bone: formation by autoinduction. Science 150:893-899.
21. Kruyt MC, Dhert WJ, Oner FC, et al. 2007. Analysis of ectopic and orthotopic bone formation in cell-based tissue-engineered constructs in goats. Biomaterials 28:1798-1805.
22. Habibovic P, Yuan H, van der Valk CM, et al. 2005. 3D microenvironment as essential element for osteoinduction by biomaterials. Biomaterials 26:3565-3575.
23. Kruyt MC, De Bruijn JD, Yuan H, et al. 2004. Optimization of bone tissue engineering in goats: a peroperative seeding method using cryopreserved cells and localized bone formation in calcium phosphate scaffolds. Transplantation 77:359-365.
24. Simon AM, O'Connor JP. 2007. Dose and time-dependent effects of cyclooxygenase-2 inhibition on fracture-healing. J Bone Joint Surg [Am] 89:500-511.
25. Burwell RG. 1966. Studies in the transplantation of bone. 8. Treated composite homograft-autografts of cancellous bone: an analysis of inductive mechanisms in bone transplantation. J Bone Joint Surg [Br] 48:532-566.
26. Cancedda R, Giannoni P, Mastrogiacomo M. 2007. A tissue engineering approach to bone repair in large animal models and in clinical practice. Biomaterials 28:4240-4250.
27. Xie C, Reynolds D, Awad H, et al. 2007. Structural bone allograft combined with genetically engineered mesenchymal stem cells as a novel platform for bone tissue engineering. Tissue Eng 13:435-445.
28. Koefoed M, Ito H, Gromov K, et al. 2005. Biological effects of rAAV-caAlk2 coating on structural allograft healing. Mol Ther 12:212-218.
29. Awad HA, Zhang X, Reynolds DG, et al. 2007. Recent advances in gene delivery for structural bone allografts. Tissue Eng 13:1973- 1985.
30. Ito H, Koefoed M, Tiyapatanaputi P, et al. 2005. Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy. Nat Med 11:291-297.